Karen Hambardzumyan

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial

Karen Hambardzumyan, Rebecca Bolce, Saedís Saevarsdóttir et al. · Annals of the Rheumatic Diseases · 2014 · 98 citations · Full text

Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial

Adrian Levitsky, Kerstin Brismar, Ingiäld Hafström et al. · RMD Open · 2017 · 85 citations · Full text

Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population

Karen Hambardzumyan, Christina Hermanrud, Per Marits et al. · Scandinavian Journal of Rheumatology · 2019 · 33 citations · Full text

A Multi‐Biomarker Disease Activity Score and the Choice of Second‐Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure

Karen Hambardzumyan, Saedís Saevarsdóttir, Kristina Forslind et al. · Arthritis & Rheumatology · 2016 · 32 citations · Full text

Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies

Jeffrey R. Curtis, Cecilie Heegaard Brahe, Mikkel Østergaard et al. · Current Medical Research and Opinion · 2019 · 23 citations · Full text